Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAYER

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 26
  • 0 comments

FDA approve NAPROXEN SODIUM

Comment Full text

NOVUGEN

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 22
  • 0 comments

FDA approve LENALIDOMIDE

Comment Full text

UNICHEM

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 23
  • 0 comments

FDA approve CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Comment Full text

PRINSTON INC

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 25
  • 0 comments

FDA approve BUSULFAN

Comment Full text

ZHEJIANG POLY PHARM

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 24
  • 0 comments

FDA approve AMIODARONE HYDROCHLORIDE

Comment Full text

SOMERSET

  • FDA Approval
  • Sept. 12, 2024, 04:27 UTC
  • 19
  • 0 comments

FDA approve BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 24
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 26
  • 0 comments

FDA approve DEXMETHYLPHENIDATE HYDROCHLORIDE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 28
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

INCEPTA PHARMS LTD

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 25
  • 0 comments

FDA approve GABAPENTIN

Comment Full text
  • Previous
  • 264
  • 265
  • 266
  • 267
  • 268
  • Next

Search

News categories

  • Technical Exchange News(9977)
  • Event(412)
  • SEC News(168776)
  • FDA Approval(9377)
  • Company Report(721)
  • Business News(112444)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin